RxDoctor Payments Data

Kyle Fink, MD

Sports Medicine · Valhalla, NYNPI 1316333180

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (54.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 63.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $3,685 and has fallen 92.6% since, to $271 in 2025.

$7,344in general payments, 2019–2025

Across 47 payments — averaging $156.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Novus Surgical Solutions LLC$1K
  • Novus Surgical Consultants$1K
  • Zimmer Biomet$282
  • Biocomposites Inc$110
  • Stryker$69

What the payments were for

  • Travel & lodging$2,11729%
  • Food & beverage$1,19516%
  • Education$4,03255%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex35$4,676
Novus Surgical Solutions LLC1$1,200
Novus Surgical Consultants7$1,009
Zimmer Biomet1$282
Biocomposites Inc1$110
Stryker2$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,344 in reported general payments places this provider in the 70th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York →

Medicare billing

Part B allowed, 2024
$76,957
Medicare patients
238
Services billed
874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium31$216
Methylprednisolone13$105
Meloxicam18$72
Oxycodone Hcl16$66

Paid to pharmacies, not to this prescriber.

Other sports medicine in Valhalla

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →